An Open-label, Multiple Dose, Crossover Study to Evaluate the Drug-drug Interaction Between AJU-A51R1 and AJU-A51R2 in Healthy Volunteers
Latest Information Update: 29 Jul 2021
At a glance
- Drugs Dapagliflozin (Primary) ; Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AJU Pharm
- 29 Jul 2021 New trial record